Drug intelligence / Profile preview

Sam68 siRNA

Development stage
Preclinical
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intratumoral, Topical, Subcutaneous, Parenteral
01

Overview

Sam68 siRNA is a small interfering RNA (siRNA) designed to silence the expression of the Sam68 protein, which is encoded by the KHDRBS1 gene. Sam68 is an RNA-binding protein that acts as a scaffold for signaling molecules and is involved in alternative splicing and RNA transport. It is frequently overexpressed in various cancers, including prostate cancer, where its activation is linked to the Src tyrosine kinase pathway. By targeting Sam68 mRNA for degradation, this siRNA inhibits cell cycle progression, reduces proliferation, and increases the sensitivity of cancer cells to apoptosis-inducing agents like cisplatin.

Other names
KHDRBS1 siRNAKHDRBS-1 siRNAKHDRBS 1 siRNASam68 RNAiSam-68 RNAiSam 68 RNAi
02

Targets

KHDRBS1

Beyond the preview

Go deeper on Sam68 siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sam68 siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call